Dimensional Fund Advisors’s Immunomedics Inc IMMU Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2020
Q4 | – | Sell |
-264,808
| Closed | -$22.5M | – | 3392 |
|
|
2020
Q3 | $22.5M | Buy |
264,808
+67,066
| +34% | +$3.39M | 0.01% | 1783 |
|
|
2020
Q2 | $7.01M | Buy |
+197,742
| New | +$5.78M | ﹤0.01% | 2344 |
|
|
2019
Q1 | – | Sell |
-42,368
| Closed | -$605K | – | 3470 |
|
|
2018
Q4 | $605K | Sell |
42,368
-156,969
| -79% | -$3.12M | ﹤0.01% | 3113 |
|
|
2018
Q3 | $4.15M | Buy |
199,337
+113,240
| +132% | +$2.68M | ﹤0.01% | 2735 |
|
|
2018
Q2 | $2.04M | Buy |
+86,097
| New | +$1.73M | ﹤0.01% | 2883 |
|
|
2015
Q1 | – | Sell |
-1,300
| Closed | -$6K | – | 3419 |
|
|
2014
Q4 | $6K | Hold |
1,300
| – | – | ﹤0.01% | 3473 |
|
|
2014
Q3 | $5K | Hold |
1,300
| – | – | ﹤0.01% | 3511 |
|
|
2014
Q2 | $5K | Hold |
1,300
| – | – | ﹤0.01% | 3560 |
|
|
2014
Q1 | $5K | Sell |
1,300
-365,188
| -100% | -$1.81M | ﹤0.01% | 3569 |
|
|
2013
Q4 | $1.69M | Sell |
366,488
-37,470
| -9% | -$167K | ﹤0.01% | 2889 |
|
|
2013
Q3 | $2.5M | Sell |
403,958
-2,127
| -0.5% | -$12.2K | ﹤0.01% | 2796 |
|
|
2013
Q2 | $2.21M | Buy |
+406,085
| New | +$1.33M | ﹤0.01% | 2797 |
|
Dimensional Fund Advisors's IMMU Position: Q4 2020 in Review
Dimensional Fund Advisors sold out of Immunomedics Inc (IMMU) in Q4 2020, closing a stake of 264,808 shares — an estimated $22.5M sold.
Dimensional Fund Advisors first reported a position in IMMU in Q2 2013 and held it in 12 quarters. The position peaked at $22.5M in Q3 2020. 0 funds tracked by Wall St. Rank hold IMMU as of Q4 2020.
- Dimensional Fund Advisors reported no remaining Immunomedics Inc position as of Q4 2020 after selling out during the quarter.
- Dimensional Fund Advisors sold 264,808 Immunomedics Inc shares in Q4 2020, an estimated $22.5M.
- Dimensional Fund Advisors first reported a position in Immunomedics Inc in Q2 2013 and held it in 12 quarters.
- Dimensional Fund Advisors's Immunomedics Inc position peaked at $22.5M in Q3 2020.
- 0 funds tracked by Wall St. Rank held Immunomedics Inc as of Q4 2020.
Based on Dimensional Fund Advisors's 13F filing for Q4 2020, filed 11 Feb 2021.